Enveric Biosciences, Inc. (ENVB)

$6.69

-0.09 (-1.33%)
Rating:
Recommendation:
-
Symbol ENVB
Price $6.69
Beta 0.000
Volume Avg. 0.28M
Market Cap 10.397M
Shares () -
52 Week Range 5.9-187.0
1y Target Est -
DCF Unlevered ENVB DCF ->
DCF Levered ENVB LDCF ->
ROE -203.26% Strong Sell
ROA -182.75% Strong Sell
Operating Margin -
Debt / Equity 934.93% Strong Buy
P/E -
P/B 11.04 Strong Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest ENVB news


Healthcare
Biotechnology
NASDAQ Capital Market

Enveric Biosciences, Inc., a pharmaceutical company, engages in developing various cannabinoid medicines for cancer care. Its products pipeline includes EV104 for the treatment of osteoarthritis; EVM-101 and EVM-201 for the treatment of cancer related distress; EVM-301 for the treatment of mental health indication; EV102, a cannabinoid cream for topical skin application; and EV101, a cannabinoid and chemotherapy combination therapy. Enveric Biosciences, Inc. is headquartered in Naples, Florida.